DK3849616T3 - Medikamentafgivelsessystem til platinbaserede medikamenter - Google Patents
Medikamentafgivelsessystem til platinbaserede medikamenter Download PDFInfo
- Publication number
- DK3849616T3 DK3849616T3 DK19769485.4T DK19769485T DK3849616T3 DK 3849616 T3 DK3849616 T3 DK 3849616T3 DK 19769485 T DK19769485 T DK 19769485T DK 3849616 T3 DK3849616 T3 DK 3849616T3
- Authority
- DK
- Denmark
- Prior art keywords
- platinum
- delivery system
- drug delivery
- based drugs
- drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
- A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
- A61K47/6931—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
- A61K47/6939—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being a polysaccharide, e.g. starch, chitosan, chitin, cellulose or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
- A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
- A61K47/6931—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
- A61K47/6935—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being obtained otherwise than by reactions involving carbon to carbon unsaturated bonds, e.g. polyesters, polyamides or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18306201 | 2018-09-14 | ||
PCT/EP2019/074739 WO2020053445A1 (en) | 2018-09-14 | 2019-09-16 | Drug delivery sytem for platinum-based drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3849616T3 true DK3849616T3 (da) | 2022-09-12 |
Family
ID=63708256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK19769485.4T DK3849616T3 (da) | 2018-09-14 | 2019-09-16 | Medikamentafgivelsessystem til platinbaserede medikamenter |
Country Status (8)
Country | Link |
---|---|
US (1) | US20220054424A1 (da) |
EP (1) | EP3849616B1 (da) |
JP (1) | JP7235870B2 (da) |
CN (1) | CN112823026B (da) |
CA (1) | CA3111861C (da) |
DK (1) | DK3849616T3 (da) |
ES (1) | ES2927608T3 (da) |
WO (1) | WO2020053445A1 (da) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2713813C (en) | 2008-01-30 | 2017-12-05 | University Of Kansas | Intralymphatic chemotherapy drug carriers |
WO2010049562A1 (es) * | 2008-10-28 | 2010-05-06 | Universidade De Santiago De Compostela | Sistemas nanoparticulares elaborados a base de polímeros aniónicos. |
EP2481396A4 (en) | 2009-09-21 | 2014-03-05 | Jw Pharmaceutical Corp | OXALIPLATIN NANOPARTICLES AND MANUFACTURING METHOD THEREFOR |
CN102813937A (zh) * | 2012-06-12 | 2012-12-12 | 天津大学 | 含有疏水性药物的聚电解质复合物及其制备方法和应用 |
CN105451720A (zh) * | 2013-03-13 | 2016-03-30 | 马林克罗特有限公司 | 用于癌症疗法的脂质体奥沙利铂组合物 |
TWI482634B (zh) | 2013-10-24 | 2015-05-01 | Ind Tech Res Inst | 生醫組合物 |
KR101616623B1 (ko) | 2014-07-24 | 2016-04-29 | 연세대학교 산학협력단 | 양이온성 고분자가 결합된 소수성 약물 및 음이온성 고분자가 결합된 친수성 약물을 포함하는 나노입자 |
US10632081B2 (en) * | 2014-10-14 | 2020-04-28 | Industrial Technology Research Institute | Intralymphatic delivery of hyaluronan nanoparticle for cancer metastasis |
US20190015518A1 (en) | 2016-01-04 | 2019-01-17 | University Of Kansas | Drug delivery compositions and methods |
CN107019706A (zh) * | 2017-03-31 | 2017-08-08 | 福州大学 | 一种顺铂‑醛基化透明质酸纳米复合物及其制备方法 |
-
2019
- 2019-09-16 US US17/274,918 patent/US20220054424A1/en active Pending
- 2019-09-16 EP EP19769485.4A patent/EP3849616B1/en active Active
- 2019-09-16 WO PCT/EP2019/074739 patent/WO2020053445A1/en unknown
- 2019-09-16 ES ES19769485T patent/ES2927608T3/es active Active
- 2019-09-16 CN CN201980059800.1A patent/CN112823026B/zh active Active
- 2019-09-16 DK DK19769485.4T patent/DK3849616T3/da active
- 2019-09-16 JP JP2021538924A patent/JP7235870B2/ja active Active
- 2019-09-16 CA CA3111861A patent/CA3111861C/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20220054424A1 (en) | 2022-02-24 |
CN112823026A (zh) | 2021-05-18 |
WO2020053445A1 (en) | 2020-03-19 |
CA3111861C (en) | 2023-11-07 |
EP3849616A1 (en) | 2021-07-21 |
JP2022508458A (ja) | 2022-01-19 |
CA3111861A1 (en) | 2020-03-19 |
CN112823026B (zh) | 2023-10-13 |
ES2927608T3 (es) | 2022-11-08 |
EP3849616B1 (en) | 2022-07-13 |
JP7235870B2 (ja) | 2023-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3755404T3 (da) | Dosisdetekteringssystemmodul til lægemiddelafgivelsesanordning | |
CA196050S (en) | Drug delivery device | |
DK3484547T3 (da) | Dosisdetekteringsmodul til medicinindgivelsesanordning | |
DK3886944T3 (da) | Lægemiddelafgivelsesindretning | |
DK3337539T3 (da) | Medikamenttilførselsanordning til variable enkeltdoser | |
IL276784A (en) | Drug delivery systems | |
DK3684447T3 (da) | Tilbehørsindretning til lægemiddelleveringsindretning | |
DK3310800T3 (da) | Leveringssystem til styret lægemiddelfrigivelse | |
EP3445416A4 (en) | ENTERALES ACTIVE COMPOSITION SYSTEM | |
EP3697479C0 (en) | SPACER ASSEMBLY FOR MEDICATION DELIVERY DEVICE | |
DK3628004T3 (da) | Selvregulerende osmotiske mave-tarm tilbageholdende leveringssystemer til lægemiddel | |
EP3664885A4 (en) | TRANSDERMAL DRUG DELIVERY SYSTEM | |
DK3316846T3 (da) | Lægemiddeltilførselsbeholder til en automatisk lægemiddeldoseringsanordning | |
EP3377011A4 (en) | LASER-ASSISTED MEDICAMENT DELIVERY SYSTEM | |
DK3836906T3 (da) | Ekspanderbar pille til lægemiddelindgivelse | |
IL279127A (en) | Dispensing devices for drug administration | |
HUE057487T2 (hu) | Gyógyszeradagoló rendszer | |
IL274920B1 (en) | Maytansinoid-based drug delivery systems | |
EP3534987A4 (en) | ADJUSTABLE-DOSE DRUG DELIVERY SYSTEM | |
EP3880175A4 (en) | TEMPERATURE-REGULATING TRANSDERMAL DRUG DELIVERY SYSTEM | |
DK3570911T3 (da) | Medikamenttilførselsanordning | |
IL280184A (en) | Drug release devices | |
DK3449892T3 (da) | Lægemiddeludleveringsapparat | |
SG11202005291WA (en) | Priming system for drug delivery device | |
DK3570910T3 (da) | Kanyler til lægemiddelindgivelsesanordninger |